LENSAR, Inc.

NasdaqCM LNSR

LENSAR, Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2024: 47.30%

LENSAR, Inc. Gross Profit Margin is 47.30% for the Trailing 12 Months (TTM) ending September 30, 2024, a -15.08% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

LENSAR, Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2023 was 55.69%, a 5.97% change year over year.
LENSAR, Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2022 was 52.56%, a -1.79% change year over year.
LENSAR, Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2021 was 53.51%, a 0.97% change year over year.
LENSAR, Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2020 was 53.00%.

Key data

Date	Gross Profit Margin	Operating Income Margin	EBT Margin	Net Income Margin

NasdaqCM: LNSR

LENSAR, Inc.

CEO	Mr. Nicholas T. Curtis
IPO Date	Oct. 2, 2020
Location	United States
Headquarters	2800 Discovery Drive
Employees	130
Sector	Consumer Discretionary
Industries Eyewear Augmented Reality (AR) Cosmetics

Description

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.

Key trends

Past 5 years